Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics

NCT02218996 | Active Not Recruiting

• 1 other identifier: ID416
• Study Type: observational
• Target: 260
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.

Conditions

Anxiety Disorders

Keywords

Anxiety; Children; Adolescent; Effectiveness; Outpatient

Outcome Measures

Primary Outcomes (1)

• The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).

  Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders.

  The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

Secondary Outcomes (6)

• Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013)

  This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

• The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999).

  This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

• Spence Children's Anxiety Scale (SCAS; Spence, 1998)

  This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

• The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)

  This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)

• Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995).

  This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)

Study Arms (1)

Psychosocial treatment

Children and adolescents with anxiety disorders

Other: Psychosocial treatment

Interventions

Psychosocial treatment OTHER

Regular psychosocial treatment in clinical outpatient service.

Psychosocial treatment

Eligibility Criteria

• Age: 7 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Children/adolescents from 7-17 years old referred to ordinary outpatient mental health service.

You may qualify if:

• Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman \& Albano, 1996).
• The anxiety disorder is the patients primary diagnosis.
• Informed concent is given.

You may not qualify if:

• The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)

Sponsors & Collaborators

• Helse Stavanger HF: lead
• Helse Vest: collaborator

Study Sites (1)

BUPA Helse Stavanger

Stavanger, Rogaland, 4011, Norway

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

• Jon F Bjaastad, D. Psych

  Division of Psychiatry, Stavanger University Hospital, N-4068 Stavanger, Norway

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 8, 2014
• First Posted: August 18, 2014
• Study Start: August 1, 2014
• Primary Completion (Estimated): December 31, 2028
• Study Completion (Estimated): December 31, 2029
• Last Updated: December 18, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)